Real-time enrollment status for this epithelial ovarian cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 6:09 AM UTC
| NCT Number | NCT06469281 |
| Recruiting Status | Recruiting |
| Condition | Epithelial Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 90 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | February 3, 2026 (Feb 3, 2026) |
As of August 28, 2026: Clinical trial NCT06469281 is currently recruiting participants. This phase1 study for epithelial ovarian cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06469281 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06469281 was last updated Feb 3, 2026 (February 3, 2026). HelloStudys verifies this status automatically.